A Mott-like State of Molecules

We prepare a quantum state where each site of an optical lattice is occupied by exactly one molecule. This is the same quantum state as in a Mott insulator of molecules in the limit of negligible tunneling. Unlike previous Mott insulators, our system consists of molecules which can collide inelastically. In the absence of the optical lattice these collisions would lead to fast loss of the molecules from the sample. To prepare the state, we start from a Mott insulator of atomic 87Rb with a central region, where each lattice site is occupied by exactly two atoms. We then associate molecules using a Feshbach resonance. Remaining atoms can be removed using blast light. Our method does not rely on the molecule-molecule interaction properties and is therefore applicable to many systems.Comment: Proceedings of the 20th International Conference on Atomic Physics (ICAP 2006), edited by C. Roos, H. Haffner, and R. Blatt, AIP Conference Proceedings, Melville, 2006, Vol. 869, pp. 278-28

Simple pressure-tuned Fabry–Pérot interferometer

A simple, compact and inexpensive pressure-tuned Fabry–Pérot interferometer is presented. It is used as a laser locking reference for optical frequencies where the use of an atomic reference is impractical. The scanning range is several GHz. Absolute positioning of the interferometer with an accuracy of 7 MHz7MHz rms over a range of 2 GHz2GHz is possible. The instrument is temperature stabilized and shows long-term drift of 16 MHz16MHz rms over 48 h48h.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87892/2/033105_1.pd

Time evolution of Matrix Product States

In this work we develop several new simulation algorithms for 1D many-body quantum mechanical systems combining the Matrix Product State variational ansatz with Taylor, Pade and Arnoldi approximations to the evolution operator. By comparing all methods with previous techniques based on Trotter decompositions we demonstrate that the Arnoldi method is the best one, reaching extremely good accuracy with moderate resources. Finally we apply this algorithm to studying the formation of molecules in an optical lattices when crossing a Feschbach resonance with a cloud of two-species hard-core bosons.Comment: More extensive comparison with all nearest-neighbor spin s=1/2 models. The results in this manuscript have been superseded by a more complete work in cond-mat/061021

The burden of childhood atopic dermatitis in the primary care setting: a report from the Meta-LARC Consortium

Background: Little is known about the burden of AD encountered in U.S. primary care practices and the frequency and type of skin care practices routinely used in children. Objectives: To estimate the prevalence of AD and allergic comorbidities in children 0-5 years attending primary care practices in the U.S. and to describe routine skin care practices used in this population. Design: A cross-sectional survey study of a convenience sample of children under the age of 5 attending primary care practices for any reason. Setting: Ten primary care practices in five U.S. states.Results: Amongst 652 children attending primary care practices, the estimated prevalence of ever having AD was 24 % (95% CI= 21-28) ranging from 15% among those under the age of one to 38% among those aged 4- 5 years. The prevalence of comorbid asthma was higher among AD participants compared to those with no AD, 12% and 4%, respectively (p less than 0.001). Moisturizers with high water:oil ratios were most commonly used (i.e., lotions) in the non-AD population, whereas moisturizers with low water:oil content (i.e. ointments) most common when AD was present. Conclusions: Our study found a large burden of AD in the primary care practice setting in the U.S. The majority of households reported skin care practices in children without AD that may be detrimental to the skin barrier such as frequent bathing and the routine use of moisturizers with high water: oil ratios. Clinical trials are needed to identify which skin care practices are optimal for reducing the significant risk of AD in the community

Reconciling global-model estimates and country reporting of anthropogenic forest CO2 sinks

This is the author accepted manuscript. The final version is available from Springer Nature via the DOI in this recordData availability: The data that support the findings of this study are available from the corresponding author upon request.Achieving the long-term temperature goal of the Paris Agreement requires forest-based mitigation. Collective progress towards this goal will be assessed by the Paris Agreement’s Global stocktake. At present, there is a discrepancy of about 4 GtCO2yr−1in global anthropogenic net land-use emissions between global models (reflected in IPCC assessment reports) and aggregated national GHG inventories (under the UNFCCC). We show that a substantial part of this discrepancy (about 3.2 GtCO2yr−1) can be explained by conceptual differences in anthropogenic forest sink estimation, related to the representation of environmental change impacts and the areas considered as managed. For a more credible tracking of collective progress under the Global stocktake, these conceptual differences between models and inventories need to be reconciled. We implement a new method of disaggregation of global land model results that allows greater comparability with GHG inventories. This provides a deeper understanding of model–inventory differences, allowing more transparent analysis of forest-based mitigation and facilitating a more accurate Global stocktake.J.H. was supported by EU FP7 through project LUC4C (GA603542) and the UK NERC project GGRiLS-GAP. G.G. was supported by Administrative Arrangement Number 340203/2016/742550/SER/CLIMA.A3. A.K.J. was supported by the NSF (AGS 12-43071) and DOE (DE-SC0016323). J.E.M.S.N. was supported by the German Research Foundation’s Emmy Noether Programme (grant number PO1751/1-1). G.G., J.H., G.P.P. and L.P. received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 776810 (VERIFY). C.D.K. was supported by the US DOE under Contract DE-AC02-05CH11231 as part of their RGMA (BGC-Feedbacks SFA) and TES Programs (NGEE-Tropics). A.K.J. was supported under the US NSF (NSF-AGS-12-43071)

Evaluating compulsory minimum volume standards in Germany: how many hospitals were compliant in 2004?

<p>Abstract</p> <p>Background</p> <p>Minimum hospital procedure volumes are discussed as an instrument for quality assurance. In 2004 Germany introduced such annual minimum volumes nationwide on five surgical procedures: kidney, liver, stem cell transplantation, complex oesophageal, and pancreatic interventions. The present investigation is the first part of a study evaluating the effects of these minimum volumes on health care provision. Research questions address how many hospitals and cases were affected by minimum volume regulations in 2004, how affected hospitals were distributed according to minimum volumes, and how many hospitals within the 16 German states complied with the standards set for 2004.</p> <p>Methods</p> <p>The evaluation is based on the mandatory hospital quality reports for 2004. In the reports, all hospitals are statutorily obliged to state the number of procedures performed for each minimum volume. The data were analyzed descriptively.</p> <p>Results</p> <p>In 2004, 485 out of 1710 German hospitals providing acute care and approximately 0.14% of all hospital cases were affected by minimum volume regulations. Liver, kidney, and stem cell transplantation affected from 23 to hospitals; complex oesophageal and pancreatic interventions affected from 297 to 455 hospitals. The inter-state comparison of the average hospital care area demonstrates large differences between city states and large area states and the eastern and western German states ranging from a minimum 51 km²up to a maximum 23.200 km², varying according to each procedure. A range of 9% – 16% of the transplantation hospitals did not comply with the standards affecting 1% – 2% of the patients whereas 29% and 18% of the hospitals treating complex oesophageal and pancreatic interventions failed the standards affecting 2% – 5% of the prevailing cases.</p> <p>Conclusion</p> <p>In 2004, the newly introduced minimum volume regulations affected only up to a quarter of German acute care hospitals and few cases. However, excluding the hospitals not meeting the minimum volume standards from providing the respective procedures deserves considering two aspects: the hospital health care provision concepts by the German states as being responsible and from a patient perspective the geographically equal access to hospital care.</p

Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression

Metformin, a Type II diabetic treatment drug, which inhibits transcription of gluconeogenesis genes, has recently been shown to lower the risk of some diabetes-related tumors, including breast cancer. Recently, “cancer stem cells” have been demonstrated to sustain the growth of tumors and are resistant to therapy. To test the hypothesis that metformin might be reducing the risk to breast cancers, the human breast carcinoma cell line, MCF-7, grown in 3-dimensional mammospheres which represent human breast cancer stem cell population, were treated with various known and suspected breast cancer chemicals with and without non-cytotoxic concentrations of metformin. Using OCT4 expression as a marker for the cancer stem cells, the number and size were measured in these cells. Results demonstrated that TCDD (100 nM) and bisphenol A (10 µM) increased the number and size of the mammospheres, as did estrogen (10 nM E2). By monitoring a cancer stem cell marker, OCT4, the stimulation by these chemicals was correlated with the increased expression of OCT4. On the other hand, metformin at 1 and 10 mM concentration dramatically reduced the size and number of mammospheres. Results also demonstrated the metformin reduced the expression of OCT4 in E2 & TCDD mammospheres but not in the bisphenol A mammospheres, suggesting different mechanisms of action of the bisphenol A on human breast carcinoma cells. In addition, these results support the use of 3-dimensional human breast cancer stem cells as a means to screen for potential human breast tumor promoters and breast chemopreventive and chemotherapeutic agents

Epigenetic reprogramming of breast cancer cells with oocyte extracts

<p>Abstract</p> <p>Background</p> <p>Breast cancer is a disease characterised by both genetic and epigenetic alterations. Epigenetic silencing of tumour suppressor genes is an early event in breast carcinogenesis and reversion of gene silencing by epigenetic reprogramming can provide clues to the mechanisms responsible for tumour initiation and progression. In this study we apply the reprogramming capacity of oocytes to cancer cells in order to study breast oncogenesis.</p> <p>Results</p> <p>We show that breast cancer cells can be directly reprogrammed by amphibian oocyte extracts. The reprogramming effect, after six hours of treatment, in the absence of DNA replication, includes DNA demethylation and removal of repressive histone marks at the promoters of tumour suppressor genes; also, expression of the silenced genes is re-activated in response to treatment. This activity is specific to oocytes as it is not elicited by extracts from ovulated eggs, and is present at very limited levels in extracts from mouse embryonic stem cells. Epigenetic reprogramming in oocyte extracts results in reduction of cancer cell growth under anchorage independent conditions and a reduction in tumour growth in mouse xenografts.</p> <p>Conclusions</p> <p>This study presents a new method to investigate tumour reversion by epigenetic reprogramming. After testing extracts from different sources, we found that axolotl oocyte extracts possess superior reprogramming ability, which reverses epigenetic silencing of tumour suppressor genes and tumorigenicity of breast cancer cells in a mouse xenograft model. Therefore this system can be extremely valuable for dissecting the mechanisms involved in tumour suppressor gene silencing and identifying molecular activities capable of arresting tumour growth. These applications can ultimately shed light on the contribution of epigenetic alterations in breast cancer and advance the development of epigenetic therapies.</p

Lower land-use emissions responsible for increased net land carbon sink during the slow warming period

The terrestrial carbon sink accelerated during 1998–2012, concurrently with the slow warming period, but the mechanisms behind this acceleration are unclear. Here we analyse recent changes in the net land carbon sink (NLS) and its driving factors, using atmospheric inversions and terrestrial carbon models. We show that the linear trend of NLS during 1998–2012 is about 0.17 ± 0.05 Pg C yr−2 , which is three times larger than during 1980–1998 (0.05 ± 0.05 Pg C yr−2). According to terrestrial carbon model simulations, the intensification of the NLS cannot be explained by CO2 fertilization or climate change alone. We therefore use a bookkeeping model to explore the contribution of changes in land-use emissions and find that decreasing land-use emissions are the dominant cause of the intensification of the NLS during the slow warming period. This reduction of land-use emissions is due to both decreased tropical forest area loss and increased afforestation in northern temperate regions. The estimate based on atmospheric inversions shows consistently reduced land-use emissions, whereas another bookkeeping model did not reproduce such changes, probably owing to missing the signal of reduced tropical deforestation. These results highlight the importance of better constraining emissions from land-use change to understand recent trends in land carbon sinks